Estrogen Deficiency on Cardiovascular Risk

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To explore how estrogen deficiency impacts the blood pressure (BP) and sympathetic nerve activity (SNA), and how it impacts the production of the key pro-inflammatory mediators such as Tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). It is hypothesized that estrogen deficiency increases BP, SNA and the pathway activities of the key pro-inflammatory mediators. Those effects are impacted through the downregulation of the estrogen receptor.
Epistemonikos ID: 6c91909df6059d5e986b643caaa5e657b4ce240b
First added on: May 15, 2024